AF
VIR icon

Allworth Financial’s Vir Biotechnology VIR Stock Holding History

Allworth Financial’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.7K Sell
3,757
-573
-13% -$4.57K ﹤0.01% 2615
2025
Q4 		$26.1K Sell
4,330
-81
-2% -$482 ﹤0.01% 2631
2025
Q3 		$25.2K Buy
4,411
+769
+21% +$3.93K ﹤0.01% 2562
2025
Q2 		$18.4K Hold
3,642
– – ﹤0.01% 2573
2025
Q1 		$22.9K Sell
3,642
-267
-7% -$2.37K ﹤0.01% 1998
2024
Q4 		$41.2K Buy
3,909
+267
+7% +$2.11K ﹤0.01% 1675
2024
Q3 		$27.3K Sell
3,642
-106
-3% -$921 ﹤0.01% 1718
2024
Q2 		$37.6K Sell
3,748
-221
-6% -$2.12K ﹤0.01% 1512
2024
Q1 		$40.2K Sell
3,969
-42
-1% -$428 ﹤0.01% 1391
2023
Q4 		$40.4K Buy
4,011
+188
+5% +$1.72K ﹤0.01% 1279
2023
Q3 		$35.8K Buy
3,823
+1
+0% +$14 ﹤0.01% 1242
2023
Q2 		$93.8K Sell
3,822
-688
-15% -$17.3K ﹤0.01% 917
2023
Q1 		$105K Sell
4,510
-711
-14% -$18.2K ﹤0.01% 839
2022
Q4 		$132K Buy
5,221
+3
+0.1% +$74 ﹤0.01% 734
2022
Q3 		$101K Buy
5,218
+97
+2% +$2.47K ﹤0.01% 768
2022
Q2 		$130K Buy
5,121
+21
+0.4% +$490 ﹤0.01% 651
2022
Q1 		$131K Buy
5,100
+4,916
+2,672% +$146K ﹤0.01% 656
2021
Q4 		$8K Buy
+184
New +$7.21K ﹤0.01% 1484
2021
Q2 		– Sell
-65
Closed -$3K – 1672
2021
Q1 		$3K Buy
+65
New +$3.5K ﹤0.01% 1254

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Allworth Financial's VIR Position: Q1 2026 in Review

Allworth Financial reduced its Vir Biotechnology (VIR) stake by 13% in Q1 2026, selling an estimated $4.57K and leaving 3,757 shares worth $33.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2615.

Allworth Financial first reported a position in VIR in Q1 2021 and has held it in 19 quarters since. The position peaked at $132K in Q4 2022. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Allworth Financial held 3,757 shares of Vir Biotechnology worth $33.7K as of Q1 2026.
  • Allworth Financial sold 573 Vir Biotechnology shares in Q1 2026, an estimated $4.57K.
  • Vir Biotechnology made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #2615 holding.
  • Allworth Financial first reported a position in Vir Biotechnology in Q1 2021 and has held it in 19 quarters since.
  • Allworth Financial's Vir Biotechnology position peaked at $132K in Q4 2022.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.